Designer cytokines for human haematopoietic progenitor cell expansion: Impact for tissue regeneration

Handbook of Experimental Pharmacology

Volumn 174, Issue , 2006, Pages 229-247

  Rose John, S ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytokine; Expansion; Haematopoietic stem cell; Receptor; Transcription factor

Indexed keywords

EID: 85099485917     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-31265-x_10     Document Type: Article

References (91)

1. Abel S, Hundhausen C, Mentlein R, Berkhout TA, Broadway N, Siddall H, Dietrich S, Muetze B, Kallen KJ, Saftig P, Rose-John S, Ludwig A (2004) The transmembrane CXC-chemokine CXCL16 is expressed on vascular cells and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172:6362-6372
2. Althoff K, Reddy P, Peschon J, Voltz N, Rose-John S, Müllberg J (2000) Contribution of the amino acid sequence at the cleavage site to the cleavage pattern of transmembrane proteins. Eur J Biochem 267:2624-2631
3. Althoff K, Müllberg J, Aasland D, Voltz N, Kallen K-J, Grötzinger J, Rose-John S (2001) Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J 353:663-672
4. Antonchuk J, Sauvageau G, Humphries RK (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45
5. Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, HoltmannM, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, NeurathMF (2000) Blockade of IL-6 transsignaling abrogates established experimental colitis in mice by suppression of the antiapoptotic resistance of lamina propria T cells. Nature Med 6: 583-588
6. Audet J, Miller CL, Rose-John S, Piret JM, Eaves CJ (2001) Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic cells. Proc Natl Acad Sci U S A 98:1757-1762
7. BeckerC, FantiniMC, SchrammC, LehrHA, WirtzS, NikolaevA, BurgJ, StrandS, KiesslichR, HuberS, ItoH, NishimotoN, YoshizakiK, KishimotoT, GallePR, BlessingM, Rose-JohnS, NeurathMF (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21:491-501
8. Brown S, Hu N, Hombria JC (2001) Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless. Curr Biol 11:1700-1705
9. Bruno S, Gunetti M, Gammaitoni L, Perissinotto E, Caione L, Sanavio F, Fagioli F, Aglietta M, Piacibello W (2004) Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Stem Cells 22:135-143
10. Chambers I, Smith A (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23:7150-7160
11. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655
12. Chebath J, Fischer D, Kumar A, Oh JW, Kolett O, Lapidot T, Fischer M, Rose-John S, Nagler A, Slavin S, Revel M (1997) Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. Eur Cytokine Netw 8:359-365
13. Conneally E, Cashman J, Petzer A, Eaves CJ (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphomyeloid repopulating activity in NOD/SCID mice. ProcNatlAcad SciUSA94:9836-9841
14. Daheron L, Opitz SL, Zaehres H, Lensch WM, Andrews PW, Itskovitz-Eldor J, Daley GQ (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22:770-778
15. Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630-1635
16. De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, KuangW-J, Oles KJ, Hultgren B, Solberg LA, GoeddelDV, EatonDL (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-538
17. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer JB, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752-760
18. Eaves C, Miller C, Conneally E, Audet J, Oostendorp R, Cashman J, Zandstra P, Rose-John S, Piret P, Eaves A (1999) Introduction to stem cell biology in vitro: threshold to the future. Ann N Y Acad Sci 872:1-8
19. Fischer M, Goldschmitt J, Peschel C, Kallen KJ, Brakenhoff JPJ, Wollmer A, Grötzinger J, Rose-John S (1997) A designer cytokine with high activity on human hematopoietic progenitor cells. Nature Biotech 15:142-145
20. Galun E, Zeira E, Shouval D, Pappo O, Peters M, Rose-John S (2000) Liver regeneration inducedby a designed hIL-6/shIL-6R fusionprotein reverses severehepatocellular injury. FASEB J 14:1979-1987
21. Goncalves F, Lacout C, Villeval JL, Wendling F, Vainchenker W, Dumenil D (1997) Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation. Blood 89:3544-3553
22. Grötzinger J, Kurapkat G, Wollmer A, Kalai M, Rose-John S (1997) The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins: Structure, Function, Genetics 27:96-109
23. Hacker C, KirschRD, Ju X-S, Hieronymus T, Gust TC, Kuhl C, Jorgas T, Kurz SM, Rose-John S, Yokota Y, Zenke M (2003) Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 4:380-386
24. Harrison DA, McCoon PE, Binari R, Gilman M, Perrimon N (1988) Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway. Genes Dev 12:3252-3263
25. Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH (2001) Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Therap 3:683-687
26. Heike T, Nakahata T (2002) Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta 1592:313-321
27. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL) -6-type cytokine signalling and its regulation. Biochem J 374:1-20
28. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo M, Rose-John S, Hayek A (2004) Maintenance of pluripotency in humanembryonic stemcells is Stat3 independent. Stem Cells 22:522-530
29. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen K-J, Rose-John S, Ludwig A (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195
30. Ikebuchi K, Wong GG, Clark SC, Ihle JN, HiraiY, OgawaM (1987) Interleukin 6 enhancement of interleukin 3-dependent proliferation ofmultipotentialhemopoietic progenitors. Proc Natl Acad Sci U S A 84:9035-9039
31. IwamaA, OguroH, NegishiM, KatoY, MoritaY, Tsukui H, EmaH, KamijoT, Katoh-FukuiY, Koseki H, van Lohuizen M, Nakauchi H (2004) Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21:843-851
32. Jones S, Rose-John S (2002) The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta 1592:251-264
33. Kallen K-J (2002) The role of transsignalling via the agonistic soluble IL-6 receptor. Biochim Biophys Acta 1592:323-343
34. Kiger AA, Jones DL, Schulz C, RogersMB, Fuller MT (2001) Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 294:2542-2545
35. Klouche M, Bhakdi S, Hemmes M, Rose-John S (1999) Novel path of activation of primary human smooth muscle cells: upregulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J Immunol 163:4583-4589
36. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G (2003) In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 9:1428-1432
37. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, HeipelMD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O-Hara PJ, Hagen FS, Roth GJ, Foster DC (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-568
38. Lust JA, Donovan KA, KlineMP, Greipp PR, Kyle RA, Maihle NJ (1992) Isolation of anmRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96-100
39. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S (1992) Complex of soluble humanIL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 149:2021-2027
40. Maione D, Di Carlo E, Li W, Musiani P, Modesti A, Peters M, Rose-John S, Della Rocca C, Tripodi M, Lazzaro D, Taub R, Savino R, Ciliberto G (1998) Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 17:5588-5597
41. März P, Cheng J-C, Gadient RA, Patterson P, Stoyan T, Otten U, Rose-John S (1998) Sympathetic neurons can produce and respond to Interleukin-6. Proc Natl Acad Sci U S A 95:3251-3256
42. März P, Otten U, Rose-John S (1999) Neuronal activities of IL-6 type cytokines often depend on soluble cytokine receptors. Eur J Neurosci 11:2995-3004
43. Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T (1999) STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 18:4261-4269
44. Matthews V, Schuster B, Schütze S, Bumeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen K-J, Rose-John S (2003) Cellular cholesterol depletion triggers sheddingof thehumaninterleukin-6 receptorbyADAM10andADAM17 (TACE) . J Biol Chem 278:38829-38839
45. Miller CL, Eaves CJ (1997) Expansion in vitro of adult murine hematopoietic cells with transplantable lympho-myeloid reconstitutionability. ProcNatlAcad SciUSA94:13648-13653
46. Morgan R, Pettengell R, Sohal J (2004) The double life of HOXB4. FEBS Lett 578:1-4
47. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635-32643
48. Müllberg J, Althoff K, Jostock T, Rose-John S (2000) The importance of shedding of membrane proteins for cytokine biology. Eur Cyt Netw 11: 27-38
49. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-305
50. Pawliuk R, Eaves C, Humphries RK (1996) Evidence of both ontogeny and transplant doseregulated expansion of hematopoietic stem cells in vivo. Blood 88:2852-2858
51. Pennica D, Arce V, Swanson TA, Vejsada R, Pollock RA, Armanini M, Dudley K, Phillips HS, Rosenthal A, Kato AC, Henderson CE (1996) Cardiotrophin-1, a cytokine present in embryonicmuscle, supports long-termsurvival of spinalmotoneurons.Neuron 17:63-74
52. PetersM, Jacobs S, EhlersM, Vollmer P, Müllberg J, Wolf E, BremG, Meyer zumBüschenfelde KH, Rose-John S (1996) The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 183:1399-1406
53. Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Dienes HP, Fattori E, CilibertoG, Meyer zum Büschenfelde KH, Rose-John S (1997) Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J ExpMed 185: 755-766
54. Peters M, Müller A, Rose-John S (1998) Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92:3495-3504
55. Peters M, Blinn G, Jostock T, Schirmacher P, Meyer zum Büschenfelde KH, Galle PR, Rose-John S (2000) Combined Interleukin-6 and soluble interleukin-6 receptor accelerates murine liver regeneration. Gastroenterology 119:1663-1671
56. Peters M, Solem F, Schirmacher P, Rose-John S (2001) IL-6 and soluble IL-6R induce stemcell factor (SCF) and Flt-3 ligand expression in vivo and in vitro. Exp Hematol 29:146-155
57. Petzer AL, Zandstra PW, Piret JM, Eaves CJ (1996) Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551-2558
58. Pflanz S, Hibbert L, Mattson JD, RosalesR, VaisbergE, Bazan JF, Phillips JH, McClanahan TK, deWaalMalefyt R, Kastelein RA (2004) WSX-1 and glycoprotein 130 constitute a signaltransducing receptor for IL-27. J Immunol 172:2225-2231
59. Radbruch A, Thiel A (2004) Cell therapy for autoimmune diseases: does it have a future? Ann Rheum Dis 63 [Suppl 2]:ii96-ii101
60. Ramsfjell V, Borge O, Cui L, Jacobsen SE (1997) Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 158:5169-5177
61. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404
62. Reya T, DuncanAW, Ailles L, Domen J, SchererDC, Willert K, Hintz L, Nusse R, Weissman IL (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-414
63. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, LuiniW, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315-325
64. Rose-John S (2001) Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv Exp Med Biol 495:145-151
65. Rose-John S (2002) GP130 stimulation and the maintenance of stemcells. Trends Biotechnol 20:417-419
66. Rose-John S, Heinrich PC (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281-290
67. Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, Heinrich PC (1990) Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 190:79-83
68. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, Humphries RK (1995) Overexpression ofHOXB4 in hematopoietic cells causes the selective expansion ofmore primitive populations in vitro and in vivo.Genes Dev 9:1753-1765
69. SauvageauG, Iscove NN, HumphriesRK (2004) In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23:7223-7232
70. Schirmacher P, Peters M, Ciliberto G, Fattori E, Lotz J, Meyer zum Büschenfelde KH, Rose-John S (1998) Hepatocellular hyperplasia, plasmacytoma formation, extracellular hematopoiesis in interleukin (IL) -6/Soluble IL-6 receptor double-transgenic mice. Am J Pathol 153:639-648
71. Smith AG (2001) Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17:435-462
72. SmithAG, Heath JK, DonaldsonDD, Wong GG, Moreau J, Stahl M, RogersD (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688-690
73. Sorrentino BP (2004) Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol 4:878-888
74. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nakahata T (1995) gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci U S A 92:2859-2863
75. Sumi T, Fujimoto Y, Nakatsuji N, Suemori H (2004) STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells. Stem Cells 22:861-872
76. Taga T, Kishimoto T (1997) gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819
77. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581
78. Tajima S, Tsuji K, EbiharaY, Sui X, TanakaR, MuraokaK, YoshidaM, YamadaK, YasukawaK, Taga T, Kishimoto T, Nakahata T (1996) Analysis of interleukin-6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J ExpMed 184:1357-1364
79. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stemcell lines derived fromhumanblastocysts. Science 282:1145-1147
80. Toniatti C, Cabibbo A, Sporena E, Salvati AL, Cerretani M, Serafini S, Lahm A, Cortese R, Ciliberto G (1996) Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity. EMBO J 15:2726-2737
81. Tulina N, Matunis E (2001) Control of stemcell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 294:2546-2549
82. Viswanathan S, Benatar T, Rose-John S, Lauffenburger D, Zandstra P (2002) Maintenance of ES cell pluripotentiality is regulated by the number and types of gp130-mediated signaling complexes. Stem Cells 20:119-138
83. WangXP, SchunckM, Kallen KJ, Trautwein C, Rose-John S, ProkschE (2004) The interleukin-6 cytokine system regulates epidermal permeability barrier repair in wild-type and IL-6-deficient mice. J Invest Dermatol 123:124-131
84. Wells JA (1996) Binding in the growth hormone receptor complex. Proc Natl Acad Sci U S A 93:1-6
85. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR, Nusse R (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452
86. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684-687
87. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 241:825-828
88. Ying QL, Nichols J, Chambers I, SmithA (2003) BMPinduction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281-292
89. Yoshida K, Chambers I, Nichols J, Smith A, Saito M, Yasukawa K, Shoyab M, Taga T, Kishimoto T (1994) Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev 45:163-171
90. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ (1997) Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A 94:4698-4703
91. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM, Shigematsu H, Levantini E, Huettner CS, Lekstrom-Himes JA, Akashi K, TenenDG (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21:853-863